🔗 Permalink

Inventor profile of:

Ofer LEVY

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-10-23

Top Assignees for applications by Ofer LEVY

The entities that hold a legal rights for patent applications filed by inventor LEVY Ofer:

Children"s Medical Center Corporation 13 Boston, MA United States
Dana-Farber-Cancer Institute, Inc. 6 Boston, MA United States
The Children's Medical Center Corporation 3 Boston, MA United States
Regents of the University of Minnesota 1 Minneapolis, MN United States
The University of Montana 1 Missoula, MT United States
UNIVERSITY OF MONTANA 1 Missoula, MT United States

Recent patent applications by LEVY Ofer

Ofer LEVY from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23

US20250325659A1

Human necessities

USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE

#2 | 2025-02-06

US20250041278A1

Human necessities

TLR8 AGONIST FOR MODULATING IMMUNE RESPONSE

#3 | 2025-01-02

US20250000971A1

Human necessities

TLR4 AGONIST FOR MODULATING IMMUNE RESPONSE

#4 | 2024-05-09

US20240148864A1

Human necessities

POLYSACCHARIDE ADJUVANTS FOR VIRUS VACCINES

#5 | 2023-10-05

US20230310438A1

Human necessities

TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS

#6 | 2023-06-29

US20230201340A1

Human necessities

ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES

#7 | 2023-06-29

US20230201339A1

Human necessities

USE OF THIAZOLE AMIDE COMPOUNDS FOR MODULATING HUMAN IMMUNE RESPONSE

#8 | 2023-04-27

US20230132397A9

Human necessities

USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE

#9 | 2022-08-04

US20220242867A1

Chemistry; metallurgy

Imidazopyrimidine compounds and uses thereof

#10 | 2022-04-21

US20220118085A9

Human necessities

USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE

#11 | 2021-09-30

US20210299250A1

Human necessities

Stimulator of Interferon Genes (STING) ligands and uses thereof

#12 | 2021-08-05

US20210236632A1

Human necessities

Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response

#13 | 2020-09-10

US20200282048A1

Human necessities

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

#14 | 2020-04-09

US20200108139A1

Human necessities

Methods and compositions relating to adjuvants

#15 | 2017-08-10

US20170224811A1

Human necessities

Vaccine adjuvant compositions

InventorID:

2694494 ⎘